Private Equity Bigwigs Buy Biomet

Dec 20 2006 | 12:42pm ET

A consortium of private equity heavyweights has agreed to pay $10.9 billion for medical device manufacturer Biomet.

The group includes the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and Texas Pacific Group.

Warsaw, Ind.-based Biomet designs and manufactures musculoskeletal medical products. The deal, which offers $44 per share and was unanimously approved by Biomet’s board, awaits shareholder approval.


In Depth

AIMA: Smaller Firms Remain the Lifeblood of the Hedge Fund Industry

Jul 26 2017 | 5:55pm ET

It is a hedge fund industry truism that the largest managers receive the most attention...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Rastegar: PE Real Estate Gains Momentum as Uncertainty Rises

Jul 21 2017 | 6:04pm ET

The steady march of equity markets and fundamental shift in the direction of Fed...

 

From the current issue of